首页> 外文期刊>Chinese Jouranl of Integrative Medicine >Study of Tripterygium Associated with Nicotinamide in Treating Late-onset Autoimmune Diabetes Mellitus in Adults
【24h】

Study of Tripterygium Associated with Nicotinamide in Treating Late-onset Autoimmune Diabetes Mellitus in Adults

机译:雷公藤与烟酰胺联合治疗成人迟发性自身免疫性糖尿病的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To explore the effect of Tripterygium polyglycoside (TP) associated with nicotin-amide on the islet cell function, immune parameters and lipoperoxide (LPO) in adult patients with late-onset autoimmune diabetes mellitus (LADA). Methods: Thirty-six cases of LADA were randomly divided into three groups: TP group (n = 12), treated with TP plus orally taken metformin; combined treatment group (n = 12), treated with TP combined with nicotinamide and metformin, and control group (n = 12) treated with metformin alone. They were followed-up for 18 months. Results: (1) Compared with the control group after 9 months of treatment, postprandial plasma glucose and LPO in combined treatment group were decreased (P <0.05), and the postprandial C-peptide was higher (P<0.05). At the 18th month, the value of postprandial C-peptide in the TP and combined treatment group was higher than that in the control group. The slL-2R level of both TP and combined treatment groups were lowered (P<0.01); (2) Islet cell antibody (ICA) positive of 5 cases in the TP group and 6 cases in the combined treatment group got converted to the negative respectively, while only one in the control group at the time (P<0.05); (3) The level of LPO in the combined treatment group was significantly lower than that in the TP group at the 18th month of treatment (P<0.05). Conclusion: TP combined with nicotinamide played a role in immunity regulation, decreasing the liter of islet cell antibody and slL-2R, which also reduced the production of LPO and had a tendency to improve islet cell function in early LADA patients.
机译:目的:探讨雷公藤多甙(TP)和烟酰胺对成年迟发性自身免疫性糖尿病(LADA)成人患者胰岛细胞功能,免疫参数和脂过氧化物(LPO)的影响。方法:将36例LADA患者随机分为三组:TP组(n = 12),TP联合口服二甲双胍治疗;联合治疗组(n = 12),TP联合烟酰胺和二甲双胍治疗,对照组(n = 12),单独使用二甲双胍治疗。他们进行了18个月的随访。结果:(1)治疗9个月后,与对照组相比,联合治疗组餐后血浆葡萄糖和LPO降低(P <0.05),餐后C肽升高(P <0.05)。 TP和联合治疗组的餐后C肽值在第18个月时高于对照组。 TP和联合治疗组的slL-2R水平均降低(P <0.01); (2)TP组5例和联合治疗组6例胰岛细胞抗体(ICA)阳性分别转化为阴性,而对照组当时只有1例(P <0.05); (3)治疗第18个月,联合治疗组LPO水平显着低于TP组(P <0.05)。结论:TP联合烟酰胺起免疫调节作用,降低了胰岛细胞抗体和slL-2R的含量,降低了LPO的产生,并有改善早期LADA患者胰岛细胞功能的趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号